Loading...
Is this your company?
Check out your Company Bowl for anonymous work chats.
Get actionable career advice tailored to you by joining more bowls.
Stay ahead in opportunities and insider tips by following your dream companies.
Get personalized job recommendations and updates by starting your searches.
1
2
3
http://glassdoor.com/slink.htm?key=vMH7g
Intrexon to Announce Third Quarter Financial Results on November 12th
http://glassdoor.com/slink.htm?key=vMHAI
Precigen on LinkedIn: "Precigen President Dr. Helen Sabzevari welcomes Maryland Department of Commerce Secretary Kelly Schulz for a #GeneTherapy #GMP facility tour. #Maryland #PrecisionMedicine #ImmunoOncology Intrexon Corporation"
http://glassdoor.com/slink.htm?key=vMeym
Precigen Announces First Patient Dosed in Phase 1 Study of PRGN-3005 UltraCAR-T™ in Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Exciting News! http://glassdoor.com/slink.htm?key=vMFOp
Precigen Announces First Patient Dosed in Phase 1/1b Study of PRGN-3006 UltraCAR-T™ in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) or Higher Risk Myelodysplastic Syndrome (MDS)
